Neurotrack Technologies Inc.
Noninvasive eye-tracking technology for early Alzheimer’s detection
This article was originally published in Start Up
With Alzheimer’s researchers now looking to head off the disease in its earlier stages, the hunt is on for ways to detect its presence when patients aren’t necessarily showing symptoms. Neurotrack Technologies Inc. is building a noninvasive eye-tracking test that it believes could replace the ADAS-COG battery of neurological tests that are the current front line of diagnosis of the disease.
You may also be interested in...
Major Chinese biopharma contract services group WuXi Biologics' share price plummeted after it said external factors would contribute to it missing original revenue targets this year in multiple areas.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Research takes deep dive into the implications around exempting certain orphan drugs that may qualify for the Inflation Reduction Act’s Medicare price negotiation program, including the effect of the exemption on Medicare spending and the revenue potential of those drugs.